Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
108,213 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
689,230 views
1 reaction
Last Post ECO
by ECO
 
Started by mmmm, 03-24-2016, 05:21 AM
1 response
1,836 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by erikm, 08-03-2011, 01:34 AM
10 responses
13,878 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by lspath, 03-21-2016, 08:28 AM
4 responses
1,808 views
0 reactions
Last Post lspath
by lspath
 
Started by cheezemeister, 03-21-2016, 07:48 AM
2 responses
1,465 views
0 reactions
Last Post cheezemeister  
Started by sven.schuierer, 03-22-2016, 02:11 AM
2 responses
1,454 views
0 reactions
Last Post sven.schuierer  
Started by loyaltman, 03-17-2016, 09:14 PM
2 responses
1,710 views
0 reactions
Last Post loyaltman  
Started by efoss, 03-11-2015, 09:25 AM
6 responses
14,914 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by Flo1000, 03-22-2016, 04:08 AM
2 responses
1,477 views
0 reactions
Last Post HESmith
by HESmith
 
Started by jessica-jordan, 03-22-2016, 08:37 AM
0 responses
2,131 views
0 reactions
Last Post jessica-jordan  
Started by binfoUser, 03-21-2016, 07:17 AM
1 response
1,923 views
0 reactions
Last Post lindenb
by lindenb
 
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM
  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Working...